indomethacin has been researched along with sb 269970 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Albayrak, A; Cadirci, E; Calik, I; Calik, M; Cinar, I; Halici, Z; Sirin, B; Yayla, M | 1 |
1 other study(ies) available for indomethacin and sb 269970
Article | Year |
---|---|
LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats.
Topics: Amides; Animals; Famotidine; Gene Expression; Indomethacin; Male; Nitric Oxide Synthase Type III; Phenols; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Serotonin Receptor Agonists; Stomach Ulcer; Sulfonamides | 2020 |